Literature DB >> 20057991

[Neurogenic or idiopathic destrusor overactivity after failed antimuscarinic treatment : clinical value of external temporary electrostimulation].

J Pannek1, S Janek, J Noldus.   

Abstract

Antimuscarinic drugs are regarded as the standard treatment of detrusor overactivity (DO). However, side effects and lack of efficacy cause patients to discontinue long-term therapy. We evaluated the clinical efficacy of functional external electrostimulation (FES) as "second-line" therapy in patients with symptomatic idiopathic or neurogenic DO.In a retrospective study, 52 patients (38 women and 14 men) were evaluated at least 1 year after FES. Eighteen patients (32.7%) regarded FES as successful. No change occurred in 34 patients (65.4%) and 1 patient reported worsening of symptoms. Treatment success lasted for 13.2 months. In successfully treated patients, voiding frequency was significantly reduced from 13.3/24 h to 6.1/24 h under FES and to 6.75/24 h at follow-up. FES is a clinically useful, well-tolerated, conservative second-line treatment option after failed antimuscarinic treatment in patients with idiopathic or neurogenic DO.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20057991     DOI: 10.1007/s00120-009-2179-x

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  28 in total

1.  Maximal electrical stimulation of patients with frequency, urgency and urge incontinence. Report of 38 cases.

Authors:  M Zöllner-Nielsen; S M Samuelsson
Journal:  Acta Obstet Gynecol Scand       Date:  1992-12       Impact factor: 3.636

2.  Maximal electrical stimulation in neurogenic detrusor hyperactivity: experiences in multiple sclerosis.

Authors:  G Primus
Journal:  Eur J Med       Date:  1992-05

3.  Intravaginal electrical stimulation: a randomized, double-blind study on the treatment of mixed urinary incontinence.

Authors:  João L Amaro; Mônica O Gameiro; Paulo R Kawano; Carlos R Padovani
Journal:  Acta Obstet Gynecol Scand       Date:  2006       Impact factor: 3.636

4.  Proceedings: Electrical stimulation for urinary incontinence: a neurophysiological study.

Authors:  J V Trontelj; M Janko; C Godec; S Rakovec; M Trontelj
Journal:  Urol Int       Date:  1974       Impact factor: 2.089

Review 5.  Electrical stimulation in overactive bladder.

Authors:  L Brubaker
Journal:  Urology       Date:  2000-05       Impact factor: 2.649

Review 6.  [Perineal electrical stimulation and rehabilitation in urinary incontinence and other symptoms of non-neurologic origin].

Authors:  M Perrigot; B Pichon; A Peskine; K Vassilev
Journal:  Ann Readapt Med Phys       Date:  2008-06-26

7.  [Overactive bladder--which diagnosis investigations are necessary before initiating primary treatment?].

Authors:  B Schönberger
Journal:  Urologe A       Date:  2003-04-25       Impact factor: 0.639

8.  Burden of illness associated with lower urinary tract symptoms including overactive bladder/urinary incontinence.

Authors:  Hema Kannan; Larry Radican; Robin S Turpin; Susan C Bolge
Journal:  Urology       Date:  2009-05-09       Impact factor: 2.649

9.  Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women.

Authors:  Raquel M Arruda; Rodrigo A Castro; Gabriela C Sousa; Marair G F Sartori; Edmund C Baracat; Manoel J B C Girão
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-03-11

10.  Maximal external electrical stimulation for treatment of neurogenic or non-neurogenic urgency and/or urge incontinence.

Authors:  G Primus; G Kramer
Journal:  Neurourol Urodyn       Date:  1996       Impact factor: 2.696

View more
  2 in total

1.  Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1.

Authors:  Rosana C P Andrade; José A Neto; Luciana Andrade; Tatiane S Oliveira; Dislene N Santos; Cassius J V Oliveira; Márcio J Prado; Edgar M Carvalho
Journal:  Urology       Date:  2015-12-24       Impact factor: 2.649

Review 2.  [Overactive bladder-which treatment when?]

Authors:  J Pannek
Journal:  Urologe A       Date:  2017-12       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.